Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 5/20 | 0.65 |
| ▸ | CNR2 | P34972 | 3/20 | 0.65 |
| ▸ | FAAH | O00519 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | BLM | P54132 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.51 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4183234 | 1.00 | CNR1 (0.65) | CNR1CNR2FAAHALDH1A1HPGD | |
| SCHEMBL886853 | 1.00 | CNR1 (0.65) | CNR1CNR2FAAHALDH1A1HPGD | |
| SCHEMBL7211379 | 1.00 | CNR1 (0.65) | CNR1CNR2FAAHALDH1A1HPGD | |
| SCHEMBL886852 | 1.00 | CNR1 (0.65) | CNR1CNR2FAAHALDH1A1HPGD | |
| SCHEMBL9951849 | 1.00 | CNR1 (0.65) | CNR1CNR2FAAHALDH1A1HPGD | |
| SCHEMBL6665064 | 1.00 | CNR1 (0.65) | CNR1CNR2FAAHALDH1A1HPGD | |
| SCHEMBL16400196 | 1.00 | CNR1 (0.65) | CNR1CNR2FAAHALDH1A1HPGD | |
| SCHEMBL5884581 | 1.00 | CNR1 (0.65) | CNR1CNR2FAAHALDH1A1HPGD | |
| SCHEMBL15364951 | 1.00 | CNR1 (0.65) | CNR1CNR2FAAHALDH1A1HPGD | |
| SCHEMBL7638596 | 0.98 | CNR1 (0.67) | CNR1CNR2FAAHALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020239784-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING GLYCOSYLATED CANNABINOIDS. | OCTARINE BIO IVS (DK) | 2020-12-03 | — | — | WO | claimed |
| EP-4110906-A1 | NOVEL SYSTEMS, METHODS, AND COMPOSITIONS FOR THE GLYCOSYLATION OF CANNABINOID COMPOUNDS | Trait Biosciences, Inc. (US) | 2023-01-04 | — | — | EP | disclosed |
| EP-4100000-A1 | NOVEL CANNABINOID CARRIER COMPOSITIONS HAVING ENHANCE PHARMACOKINETIC PROPERTIES AND METHODS OF USE THEREOF | Desert Harvest, Inc. (US) | 2022-12-14 | — | — | EP | disclosed |
| EP-3921436-A1 | SYSTEMS, METHODS, AND COMPOSITIONS FOR THE GENERATION OF WATER-SOLUBLE CANNABINOIDS UTILIZING FATTY-ACID BINDING PROTEINS AND FATTY-ACID BINDING-LIKE PROTEINS AS CANNABINOID-CARRIERS | Trait Biosciences, Inc. (US) | 2021-12-15 | — | — | EP | disclosed |
| EP-3921641-A1 | GENERATION OF WATER-SOLUBLE CANNABINOIDS UTILIZING PROTEIN CANNABINOID-CARRIERS | Trait Biosciences, Inc. (US) | 2021-12-15 | — | — | EP | disclosed |
| WO-2021183686-A1 | IMPROVED SYSTEMS, AND METHODS OF SOLVENTLESS EXTRACTION OF CANNABINOID COMPOUNDS | TRICHOME ALCHEMY LLC (US) | 2021-09-16 | — | — | WO | disclosed |
| WO-2021158251-A1 | NOVEL CANNABINOID CARRIER COMPOSITIONS HAVING ENHANCE PHARMACOKINETIC PROPERTIES AND METHODS OF USE THEREOF | DESERT HARVEST, INC. (US) | 2021-08-12 | — | — | WO | disclosed |
| WO-2020239784-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING GLYCOSYLATED CANNABINOIDS. | OCTARINE BIO IVS (DK) | 2020-12-03 | — | — | WO | disclosed |
| EP-3730145-A1 | GENERATION OF WATER-SOLUBLE CANNABINOID COMPOUNDS IN YEAST AND PLANT CELL SUSPENSION CULTURES AND COMPOSITIONS OF MATTER | Trait Biosciences, Inc. (US) | 2020-10-28 | — | — | EP | disclosed |
| WO-2020163378-A1 | SYSTEMS, METHODS, AND COMPOSITIONS FOR THE GENERATION OF WATER-SOLUBLE CANNABINOIDS UTILIZING FATTY-ACID BINDING PROTEINS AND FATTY-ACID BINDING-LIKE PROTEINS AS CANNABINOID-CARRIERS | TRAIT BIOSCIENCES, INC. (US) | 2020-08-13 | — | — | WO | disclosed |
| WO-2020163402-A1 | GENERATION OF WATER-SOLUBLE CANNABINOIDS UTILIZING PROTEIN CANNABINOID-CARRIERS | TRAIT BIOSCIENCES, INC. (US) | 2020-08-13 | — | — | WO | disclosed |
| EP-3679153-A1 | GENERATION OF WATER-SOLUBLE CANNABINOID COMPOUNDS IN YEAST AND PLANT CELL SUSPENSION CULTURES AND COMPOSITIONS OF MATTER | Trait Biosciences, Inc. (US) | 2020-07-15 | — | — | EP | disclosed |
| EP-3600361-A2 | HIGH LEVEL IN VIVO BIOSYNTHESIS AND ISOLATION OF WATER-SOLUBLE CANNABINOIDS IN PLANT SYSTEMS | Trait Biosciences, Inc. (US) | 2020-02-05 | — | — | EP | disclosed |
| WO-2019147873-A2 | SYSTEMS AND METHODS FOR ENHANCING TRICHOME FORMATION AND DENSITY IN CANNABIS | TRAIT BIOSCIENCES, INC. (US) | 2019-08-01 | — | — | WO | disclosed |
| WO-2019014395-A1 | GENERATION OF WATER-SOLUBLE CANNABINOID COMPOUNDS IN YEAST AND PLANT CELL SUSPENSION CULTURES AND COMPOSITIONS OF MATTER | TRAIT BIOSCIENCES, INC. (US) | 2019-01-17 | — | — | WO | disclosed |
| WO-2018176055-A2 | HIGH LEVEL IN VIVO BIOSYNTHESIS AND ISOLATION OF WATER-SOLUBLE CANNABINOIDS IN PLANT SYSTEMS | TRAIT BIOSCIENCES, INC. (US) | 2018-09-27 | — | — | WO | disclosed |
| EP-3352855-A1 | CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS | Vitality Biopharma, Inc. (US) | 2018-08-01 | — | — | EP | disclosed |
| WO-2017053574-A1 | CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS | VITALITY BIOPHARMA, INC. (US) | 2017-03-30 | — | — | WO | disclosed |